CN1555829A - Chinese medicinal preparation for treating cancer - Google Patents
Chinese medicinal preparation for treating cancer Download PDFInfo
- Publication number
- CN1555829A CN1555829A CNA2003101146638A CN200310114663A CN1555829A CN 1555829 A CN1555829 A CN 1555829A CN A2003101146638 A CNA2003101146638 A CN A2003101146638A CN 200310114663 A CN200310114663 A CN 200310114663A CN 1555829 A CN1555829 A CN 1555829A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- cancer
- component
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of decoction for treating esophagus cancer, stomach cancer, lung cancer and breast cancer is prepared from 9 Chinese-medicinal materials including astragalus root, pseudostellaria root, tortoise plastron, leach, etc through decocting.
Description
Technical field
The invention belongs to a kind of Chinese medicine preparation, particularly a kind of Chinese medicine preparation for the treatment of cancer is applicable to treatment esophageal carcinoma, gastric cancer, pulmonary carcinoma and breast carcinoma.
Background technology
Cancer is the topical manifestations of systemic disease, and is very big to human beings'health harm, shows according to interrelated data, and the annual patient who suffers from a cancer of China is more than 2,000,000 examples, and death has 1,600,000 people, and mortality rate accounts for 80%, and is artificially maximum with old age especially.In recent years, the incidence probability of middle age also begins to rise.The cause of death: protopathy can not the effector account for 40%; Minute lesion can not the effector account for 60%, and often just has the existing minute lesion of patient more than 50% to shift when diagnosis.In canceration, higher with esophageal carcinoma, cardiac cancer, gastric cancer, lung cancer morbidity rate especially.For treatment for cancer, adopt the method for comprehensive therapies such as operation, radiotherapy, chemotherapy usually in medical circle, obtain certain achievement, but still had a lot of weak points.Tcm therapy is the important means of treatment cancer, at present extensively certainly by medical circle, reason is: the function of Chinese medical and herbal therapy is adjustable each internal organs of complete machine body, transfer the various cancer-resisting substances of body, thereby can not only improve the effect of other therapies, can also directly control and eliminate cancerous cell, but the medicine that cure rate is higher, effect is more stable is still very few, its curative effect is not very good yet, as anticancer famous medicine " Chinese ganoderma extract ", its cancer disappearance rate only is 4%, and for example obtains " TIANXIAN WAN " of world's gold medal, and its suppression ratio to tumor cell in vitro only is 50.9%.
Summary of the invention
The objective of the invention is to further inquire into way with the treatment by Chinese herbs cancer, from set upright, aspect such as QI invigorating, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, the removing heat from blood that stimulates the menstrual flow, spleen reinforcing sending down the abnormal ascending QI, inducing diuresis to remove edema, soothing liver-QI promoting the circulation of QI starts with, and develops a kind of Chinese medicine preparation that can improve the treatment cancer of treatment of cancer effect, determined curative effect.
For reaching above purpose, the technical solution adopted in the present invention is: this a kind of Chinese medicine preparation for the treatment of cancer, it is characterized in that the component of this Chinese medicine preparation and the ratio of the shared gross weight of each component are: Radix Astragali 6-9%, Radix Pseudostellariae 3-6%, Carapax et Plastrum Testudinis 3-6%, Carapax Trionycis 3-6%, Squama Manis preparata 1-4%, unprocessed leech 1-3%, rhizoma sparganic 2-5%, Rhizoma Curcumae 3-5%, Hedyotidis Diffusae 4-6%, Herba Portulacae Grandiflorae 4-6%, Rhizoma Paridis 2-5%, Radix Angelicae Sinensis 2-4%, Flos Carthami 2-4%, Radix Paeoniae Rubra 2-4%, Radix Actinidiae Chinensis 4-6%, Rhizoma Polygoni Cuspidati 3-5%, Nidus Vespae 2-4%, Os Draconis 3-6%, Concha Ostreae 4-6%, Poria 3-5%, Rhizoma Pinelliae 2-4%, Radix Notoginseng powder 1-3%, Polyporus 3-5%, Scorpio 1-3%, Semen Coicis 3-6%, Radix Bupleuri 3-5%, other adds 2 of Scolopendras.Take by weighing the each component medicine according to the above ratio, after the mixing, decoct with water, amount of water 900-1600 gram, after big fire decocted half an hour, littler fire decocted 1 hour, filter the 1000ml decoction, sterilization is by every bottle of 300ml packing.
Instructions of taking: oral, every day three times, each 300ml.
Prescription pharmacology of the present invention is: the Radix Astragali, Radix Pseudostellariae have set upright, the effect of QI invigorating; Carapax et Plastrum Testudinis, Carapax Trionycis, Squama Manis preparata, unprocessed leech, rhizoma sparganic, Rhizoma Curcumae, Scolopendra, Scorpio have hard masses softening and resolving, relieve the pain and blood blood stasis dispelling, the promoting the circulation of QI stagnant effect of loosing; Hedyotidis Diffusae, Herba Portulacae Grandiflorae, Rhizoma Paridis have the effect of heat-clearing and toxic substances removing, removing heat from blood; Radix Angelicae Sinensis, Flos Carthami, Radix Paeoniae Rubra have enriches blood and the effect of blood blood stasis dispelling, collateral dredging; Radix Actinidiae Chinensis, Rhizoma Polygoni Cuspidati, Nidus Vespae, Os Draconis, Concha Ostreae have the effect of antitumor cell growth; Poria, Rhizoma Pinelliae have the effect of enriching spleen-QI, sending down the abnormal ascending QI, damp eliminating; Radix Notoginseng powder has the effect of hemostasis and blood; Polyporus has the effect of diuresis, diuretic, detumescence; Semen Coicis has the effect of intestine moistening, lung moistening, relieving constipation, detoxifcation; Radix Bupleuri has the soothing liver-QI promoting the circulation of QI, the effect of the liver-fire of dispelling.All medicine rational proportions and usefulness can reach the purpose that improves treatment cancer effect.
Beneficial effect of the present invention is: by clinic case clinical practice 26 examples, and effective 18 examples, total effective rate is 69.2%, in effective case, its produce effects 11 examples, its obvious effective rate is 42.3%, invalid 8 examples, inefficiency are 30.8%.
Its statistical standard is:
1, esophageal carcinoma
Produce effects: dysphagia disappears, and blocks, pain, hemorrhage disappearance.
Effectively: dysphagia alleviates, and blocks, pain, hemorrhage alleviating.
Invalid: as to swallow difficulty still, block, pain, hemorrhage no change.
2, gastric cancer
Produce effects: epigastrium is bloated painful, nausea and vomiting disappearance, hematemesis, the disappearance of having blood in stool, suffer from diarrhoea.
Effectively: expand painful, nausea and vomiting of epigastrium alleviates, hematemesis, have blood in stool, suffering from diarrhoea alleviates.
Invalid: epigastrium is still bloated aches, nausea and vomiting remains unchanged hematemesis, the no change of having blood in stool, suffer from diarrhoea.
3, pulmonary carcinoma
Produce effects: serious cough, hemoptysis disappear chest pain, uncomfortable in chest, the disappearance of breathing hard.
Effectively: serious cough, hemoptysis alleviate, chest pain, uncomfortable in chest, breathing hard alleviates.
Invalid: serious cough, hemoptysis, chest pain, uncomfortable in chest, the equal no change of breathing hard.
Embodiment 1
The ratio of the component of Chinese medicine preparation and the shared gross weight of each component is: the Radix Astragali 6%, Radix Pseudostellariae 6%, Carapax et Plastrum Testudinis 4%, Carapax Trionycis 4%, Squama Manis preparata 2%, unprocessed leech 3%, rhizoma sparganic 2%, Rhizoma Curcumae 5%, Hedyotidis Diffusae 6%, Herba Portulacae Grandiflorae 4%, Rhizoma Paridis 5%, Radix Angelicae Sinensis 2%, Flos Carthami 2%, Radix Paeoniae Rubra 4%, Radix Actinidiae Chinensis 5%, Rhizoma Polygoni Cuspidati 4%, Nidus Vespae 3%, Os Draconis 5%, Concha Ostreae 4%, Poria 4%, Rhizoma Pinelliae 2%, Radix Notoginseng powder 3%, Polyporus 4%, Scorpio 2%, Semen Coicis 5%, Radix Bupleuri 4%, other adds 2 of Scolopendras.Take by weighing the each component medicine according to the above ratio, after the mixing, decoct with water, amount of water 1000 gram, after big fire decocted half an hour, littler fire decocted 1 hour, filter the 1000ml decoction, sterilization is by every bottle of 300ml packing.
Clinical application cases 8 examples are esophageal carcinoma.Oral, every day three times, each 300ml.Time of Administration 4-6 month, its effective 7 examples, effective percentage is 87.5%, produce effects 5 examples, obvious effective rate is 62.5%, invalid 1 example accounts for 12.5%.
Embodiment 2
The ratio of the component of Chinese medicine preparation and the shared gross weight of each component is: the Radix Astragali 9%, Radix Pseudostellariae 3%, Carapax et Plastrum Testudinis 6%, Carapax Trionycis 3%, Squama Manis preparata 4%, unprocessed leech 1%, rhizoma sparganic 5%, Rhizoma Curcumae 3%, Hedyotidis Diffusae 4%, Herba Portulacae Grandiflorae 6%, Rhizoma Paridis 2%, Radix Angelicae Sinensis 3%, Flos Carthami 3%, Radix Paeoniae Rubra 2%, Radix Actinidiae Chinensis 4%, Rhizoma Polygoni Cuspidati 3%, Nidus Vespae 2%, Os Draconis 3%, Concha Ostreae 6%, Poria 5%, Rhizoma Pinelliae 3%, Radix Notoginseng powder 3%, Polyporus 3%, Scorpio 3%, Semen Coicis 6%, Radix Bupleuri 5%, other adds 2 of Scolopendras.Processing is produced with embodiment 1.
Clinical application cases 12 examples are gastric cancer.Oral, every day three times, each 300ml.Time of Administration 6-10 month, its effective 7 examples, effective percentage is 58.3%, produce effects 5 examples, obvious effective rate is 41.6%, invalid 5 examples account for 41.6%.
Embodiment 3
The ratio of the component of Chinese medicine preparation and the shared gross weight of each component is: the Radix Astragali 9%, Radix Pseudostellariae 4%, Carapax et Plastrum Testudinis 3%, Carapax Trionycis 6%, Squama Manis preparata 1%, unprocessed leech 2%, rhizoma sparganic 3%, Rhizoma Curcumae 4%, Hedyotidis Diffusae 3%, Herba Portulacae Grandiflorae 5%, Rhizoma Paridis 3%, Radix Angelicae Sinensis 4%, Flos Carthami 4%, Radix Paeoniae Rubra 3%, Radix Actinidiae Chinensis 6%, Rhizoma Polygoni Cuspidati 5%, Nidus Vespae 4%, Os Draconis 5%, Concha Ostreae 5%, Poria 3%, Rhizoma Pinelliae 4%, Radix Notoginseng powder 1%, Polyporus 5%, Scorpio 1%, Semen Coicis 3%, Radix Bupleuri 5%, other adds 2 of Scolopendras.Processing is produced with embodiment 1.
Clinical application cases 6 examples are pulmonary carcinoma.Oral, every day three times, each 300ml.Time of Administration 7-9 month, its effective 4 examples, effective percentage is 66.7%, produce effects 1 example, obvious effective rate is 16.7%, invalid 2 examples account for 33.3%.
Claims (1)
1, a kind of Chinese medicine preparation for the treatment of cancer, it is characterized in that the component of this Chinese medicine preparation and the ratio of the shared gross weight of each component are: Radix Astragali 6-9%, Radix Pseudostellariae 3-6%, Carapax et Plastrum Testudinis 3-6%, Carapax Trionycis 3-6%, Squama Manis preparata 1-4%, unprocessed leech 1-3%, rhizoma sparganic 2-5%, Rhizoma Curcumae 3-5%, Hedyotidis Diffusae 4-6%, Herba Portulacae Grandiflorae 4-6%, Rhizoma Paridis 2-5%, Radix Angelicae Sinensis 2-4%, Flos Carthami 2-4%, Radix Paeoniae Rubra 2-4%, Radix Actinidiae Chinensis 4-6%, Rhizoma Polygoni Cuspidati 3-5%, Nidus Vespae 2-4%, Os Draconis 3-6%, Concha Ostreae 4-6%, Poria 3-5%, Rhizoma Pinelliae 2-4%, Radix Notoginseng powder 1-3%, Polyporus 3-5%, Scorpio 1-3%, Semen Coicis 3-6%, Radix Bupleuri 3-5%, other adds 2 of Scolopendras.Take by weighing the each component medicine according to the above ratio, after the mixing, decoct with water, become decoction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310114663 CN1265833C (en) | 2003-12-30 | 2003-12-30 | Chinese medicinal preparation for treating cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310114663 CN1265833C (en) | 2003-12-30 | 2003-12-30 | Chinese medicinal preparation for treating cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1555829A true CN1555829A (en) | 2004-12-22 |
CN1265833C CN1265833C (en) | 2006-07-26 |
Family
ID=34337188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310114663 Expired - Fee Related CN1265833C (en) | 2003-12-30 | 2003-12-30 | Chinese medicinal preparation for treating cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1265833C (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1314409C (en) * | 2005-01-05 | 2007-05-09 | 谢志明 | Medicine for inhibiting and eliminating cancer |
CN1323710C (en) * | 2005-09-27 | 2007-07-04 | 韩云超 | Lung cancer treating Chinese medicine |
CN101954022A (en) * | 2010-10-15 | 2011-01-26 | 林万硕 | Chinese medicinal composition for treating lung cancer |
CN102743685A (en) * | 2012-01-10 | 2012-10-24 | 刘天岐 | Oldenlandia anti-cancer pills |
CN102824600A (en) * | 2012-08-20 | 2012-12-19 | 王三元 | Pure traditional Chinese medicine preparation for nourishing liver, protecting liver, softening liver and shrinking spleen and preparation method thereof |
CN104069295A (en) * | 2014-06-04 | 2014-10-01 | 于新钟 | Medicament with effects of removing tumors, resisting cancers and relieving pain |
CN104800398A (en) * | 2014-01-24 | 2015-07-29 | 郝金凤 | Decoction to treat cancer by astringent drug |
CN105456946A (en) * | 2016-01-08 | 2016-04-06 | 李树田 | Traditional Chinese medicine agentia for treating cancer |
CN105853682A (en) * | 2016-05-11 | 2016-08-17 | 张士舜 | Traditional Chinese medicinal composition for treating breast cancer and preparation method of traditional Chinese medicinal composition |
CN106237265A (en) * | 2016-09-26 | 2016-12-21 | 中山大学新华学院 | Antitumor Chinese and preparation method thereof |
CN106729407A (en) * | 2016-12-27 | 2017-05-31 | 四川西奈生物科技有限公司 | The Chinese medicine composition for the treatment of cancer |
CN108653671A (en) * | 2018-06-28 | 2018-10-16 | 辽宁传明健康产业有限公司 | A kind of anticancer drug and preparation method thereof |
CN110227130A (en) * | 2019-07-10 | 2019-09-13 | 陈海林 | A kind of Chinese medicine composition and preparation method thereof for treating breast cancer |
-
2003
- 2003-12-30 CN CN 200310114663 patent/CN1265833C/en not_active Expired - Fee Related
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1314409C (en) * | 2005-01-05 | 2007-05-09 | 谢志明 | Medicine for inhibiting and eliminating cancer |
CN1323710C (en) * | 2005-09-27 | 2007-07-04 | 韩云超 | Lung cancer treating Chinese medicine |
CN101954022A (en) * | 2010-10-15 | 2011-01-26 | 林万硕 | Chinese medicinal composition for treating lung cancer |
CN101954022B (en) * | 2010-10-15 | 2012-06-06 | 林万硕 | Chinese medicinal composition for treating lung cancer |
CN102743685A (en) * | 2012-01-10 | 2012-10-24 | 刘天岐 | Oldenlandia anti-cancer pills |
CN102824600A (en) * | 2012-08-20 | 2012-12-19 | 王三元 | Pure traditional Chinese medicine preparation for nourishing liver, protecting liver, softening liver and shrinking spleen and preparation method thereof |
CN102824600B (en) * | 2012-08-20 | 2014-07-23 | 王三元 | Pure traditional Chinese medicine preparation for nourishing liver, protecting liver, softening liver and shrinking spleen and preparation method thereof |
CN104800398A (en) * | 2014-01-24 | 2015-07-29 | 郝金凤 | Decoction to treat cancer by astringent drug |
CN104069295A (en) * | 2014-06-04 | 2014-10-01 | 于新钟 | Medicament with effects of removing tumors, resisting cancers and relieving pain |
CN105456946A (en) * | 2016-01-08 | 2016-04-06 | 李树田 | Traditional Chinese medicine agentia for treating cancer |
CN105853682A (en) * | 2016-05-11 | 2016-08-17 | 张士舜 | Traditional Chinese medicinal composition for treating breast cancer and preparation method of traditional Chinese medicinal composition |
CN106237265A (en) * | 2016-09-26 | 2016-12-21 | 中山大学新华学院 | Antitumor Chinese and preparation method thereof |
CN106237265B (en) * | 2016-09-26 | 2020-06-30 | 中山大学新华学院 | Anti-tumor traditional Chinese medicine composition and preparation method thereof |
CN106729407A (en) * | 2016-12-27 | 2017-05-31 | 四川西奈生物科技有限公司 | The Chinese medicine composition for the treatment of cancer |
CN108653671A (en) * | 2018-06-28 | 2018-10-16 | 辽宁传明健康产业有限公司 | A kind of anticancer drug and preparation method thereof |
CN110227130A (en) * | 2019-07-10 | 2019-09-13 | 陈海林 | A kind of Chinese medicine composition and preparation method thereof for treating breast cancer |
Also Published As
Publication number | Publication date |
---|---|
CN1265833C (en) | 2006-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1265833C (en) | Chinese medicinal preparation for treating cancer | |
CN102319336A (en) | Traditional Chinese medicine for treating gastritis | |
CN105233202A (en) | Preparation method of drug for treating peptic ulcers and extractive prepared according to preparation method | |
CN101125185A (en) | Traditional Chinese medicine for treating fatty liver | |
CN104758890A (en) | Traditional Chinese medicine composition for treating cough | |
CN101062221A (en) | Medicine for treating gastric ulcer and duodenal ulcer | |
CN104825736A (en) | Traditional Chinese medicine for treating hepatitis B | |
CN103705870A (en) | Traditional Chinese medicine composition for treating mastitis | |
CN103908616B (en) | The medicament of tumor remission patient radiotherapy side effect and preparation method | |
CN102416121A (en) | Application of medicinal composition to preparation of medicaments for treating gastric ulcer | |
CN102430073B (en) | Medicinal composition for treating peptic ulcer | |
CN102416120B (en) | Application of medicinal composition in preparation of medicament for treating erosive gastritis | |
CN105343344A (en) | Yin and lung nourishing formula for treating silicosis and preparation method | |
CN1186083C (en) | Chinese medicine for treating mammary gland foliole proliferation | |
CN104069342A (en) | Traditional Chinese medicine for treating acute heart failure | |
CN103479960A (en) | Chronic Hepatitis B disease treatment Chinese herbal | |
CN1537559A (en) | Traditional Chinese medicine for treating AIDS | |
CN102416122B (en) | Application of medicinal composition in preparation of medicaments for treating duodenal ulcer | |
CN102166303B (en) | Chinese medicinal composition for treating chronic atrophic gastritis | |
CN1314409C (en) | Medicine for inhibiting and eliminating cancer | |
CN1253003A (en) | Compound graceful jassamine preparation | |
CN104857126A (en) | Traditional Chinese medicine composition for treating mammitis | |
CN104547512A (en) | Pharmaceutical composition for treating pharyngeal diseases, as well as preparation method thereof | |
CN111166816A (en) | Traditional Chinese medicine ointment film for preventing and treating hyperplasia of mammary glands and preparation and use methods thereof | |
CN105477147A (en) | Traditional Chinese medicine preparation for preventing and treating synovitis and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |